Nasdaq

Broad-Spectrum Antiviral NV-387 (NV-CoV-2) in Phase 1a/1b Clinical Trial is Highly Effective in an Animal Model for MPox and Smallpox Drug Development

SHELTON, CT / ACCESSWIRE / November 14, 2023 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines ...
Forbes

Will Destruction Of Smallpox Virus Get Postponed Again?

(Original Caption) Smallpox in an unvaccinated child. Is it finally time to eliminate the remaining stocks of variola (smallpox) virus for good? The World Health Assembly will discuss the current ...
Reuters

Study shows how smallpox virus tricks healthy cells

LONDON (Reuters) - A virus closely related to smallpox disguises itself as a piece of a broken cell to trick its way into cells, Swiss researchers said on Thursday in a discovery that could lead to ...
Medical Xpress

Smallpox vaccination in childhood could offer protection against monkeypox clade II viruses, study finds

A study by co-authors from the ECDC, WHO and national public health institutes in four European countries, and published in Eurosurveillance, has found that prior smallpox vaccination in childhood ...
WGN Radio

Broad-Spectrum Antiviral NV-387 (NV-CoV-2) in Phase 1a/1b Clinical Trial is Highly Effective in an Animal Model for MPox and Smallpox Drug Development - WGN Radio 720

SHELTON, CT / ACCESSWIRE / November 14, 2023 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines ...